Evolus (EOLS) Return on Capital Employed Growth (1y) (2019 - 2026)
Evolus (EOLS) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 1,367.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,367.00 |
| Mar 31, 2026 | 871.00 |
| Dec 31, 2025 | -173.00 |
| Sep 30, 2025 | -110.00 |
| Jun 30, 2025 | -543.00 |
| Mar 31, 2025 | 429.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 1,888.00 |
| Jun 30, 2024 | 2,318.00 |
| Mar 31, 2024 | 1,953.00 |
| Dec 31, 2023 | 924.00 |
| Sep 30, 2023 | 559.00 |
| Jun 30, 2023 | -17.00 |
| Mar 31, 2023 | -1,400.00 |
| Dec 31, 2022 | -2,220.00 |
| Sep 30, 2022 | 3,772.00 |
| Jun 30, 2022 | 6,650.00 |
| Mar 31, 2022 | 9,946.00 |
| Dec 31, 2021 | 45,088.00 |
| Sep 30, 2021 | -5,610.00 |